To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CD47TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
516 supporting clones for gene CD47 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR615658 Neuroblastoma Cot 50-normalized .a 1 to 1394 1 to 1394 exact tiling clone,   1394/1394
(100 %)
0 diff
(100 %id)
AL529893 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 1 to 735 1 to 735   fully sequenced,   735/735
(100 %)
15 diff
(98.0 %id)
DB479184 hippocampus .a 14 to 453 1 to 440       440/440
(100 %)
7 diff
(98.5 %id)
NM_001777.3   .a 35 to 5380 1 to 5346   RefSeq,   5346/5346
(100 %)
1 diff
(100.0 %id)
AK289813 brain .a 94 to 1592 1 to 1499   tiling clone,   1499/1499
(100 %)
1 diff
(100.0 %id)
X69398   .a 108 to 1393 1 to 1285       1285/1285
(100 %)
5 diff
(99.7 %id)
BE879618 large cell carcinoma, undifferentiated, lung .a 434 to 1148 1 to 711       711/784
(90 %)
6 diff
(99.3 %id)
BP313636 mammary gland .a 664 to 1245 1 to 582       582/582
(100 %)
0 diff
(100 %id)
AL563587 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 674 to 1394 721 to 1   fully sequenced,   721/721
(100 %)
7 diff
(99.1 %id)
AW190446 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 674 to 1395 732 to 10       723/732
(98 %)
9 diff
(98.8 %id)
AI884400 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 740 to 1395 656 to 1       656/656
(100 %)
9 diff
(98.7 %id)
DA061239 cerebellum .a 802 to 1366 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA810750 brain .a 827 to 1385 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
AI280720 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 935 to 1407 488 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 473/473
(100 %)
4 diff
(99.2 %id)
AA834685 ovary .a 974 to 1412 449 to 12   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 438/438
(100 %)
1 diff
(99.8 %id)
AW393156 stomach .a 1087 to 1261 183 to 10       174/206
(84 %)
5 diff
(97.6 %id)
BE843150 stomach .a 1088 to 1258 177 to 10       168/177
(94 %)
4 diff
(97.8 %id)
TI_151701936   .a 1089 to 1407 446 to 128   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 319/899
(35 %)
4 diff
(99.6 %id)
AW819119 stomach .a 1091 to 1275 8 to 192       184/192
(95 %)
6 diff
(96.9 %id)
D54259   .a 1091 to 1394 324 to 24   AAA Submitted on the opposite strand 301/306
(98 %)
8 diff
(97.4 %id)
AW393132 stomach .a 1098 to 1290 1 to 193       193/198
(97 %)
6 diff
(97.0 %id)
AW818972 stomach .a 1098 to 1289 26 to 214       189/214
(88 %)
13 diff
(94.0 %id)
BE937550 stomach .a 1098 to 1289 26 to 214       189/214
(88 %)
13 diff
(94.0 %id)
BQ363985 stomach .a 1103 to 1200 1 to 98       98/101
(97 %)
6 diff
(94.1 %id)
DA830005 placenta .a 3376 to 3964 2 to 595   tiling clone, capped   594/600
(99 %)
10 diff
(98.4 %id)
EH333687   .a 3547 to 3622 1 to 76   tiling clone,   76/76
(100 %)
0 diff
(100 %id)
BE932554 head_neck .a 3585 to 3679 103 to 9       95/103
(92 %)
0 diff
(100 %id)
AJ712578 bone marrow .a 3717 to 3868 1 to 152   tiling clone,   152/152
(100 %)
1 diff
(99.4 %id)
AA376836 small intestine .a 3842 to 4013 1 to 172   tiling clone,   172/172
(100 %)
0 diff
(100 %id)
D54231   .a 4038 to 4418 1 to 381   tiling clone,   381/381
(100 %)
2 diff
(99.5 %id)
D55274   .a 4038 to 4372 1 to 335       335/335
(100 %)
3 diff
(99.2 %id)
AV724531 hypothalamus .a 4044 to 4619 567 to 1   tiling clone, AAA Submitted on the opposite strand 567/567
(100 %)
7 diff
(98.8 %id)
AA251087 germinal center B cell .a 4056 to 4481 1 to 426     Submitted on the opposite strand 426/426
(100 %)
0 diff
(100 %id)
DN920221   .a 4059 to 4373 1 to 315       315/315
(100 %)
0 diff
(100 %id)
BE348320 carcinoid, lung .a 4059 to 4583 1 to 525     Submitted on the opposite strand 525/525
(100 %)
0 diff
(100 %id)
BF085805 placenta_normal .a 4082 to 4348 274 to 8       267/274
(97 %)
0 diff
(100 %id)
D31589   .a 4115 to 4294 1 to 180       180/180
(100 %)
0 diff
(100 %id)
AA621574   .a 4128 to 4585 1 to 458     Submitted on the opposite strand 458/458
(100 %)
3 diff
(99.4 %id)
BU165136 epithelioid carcinoma, Pancreas .a 4135 to 4884 1 to 757       757/898
(84 %)
14 diff
(98.5 %id)
BG483558 lung .a 4140 to 4853 1 to 717       717/718
(99 %)
15 diff
(98.0 %id)
AA765954 germinal center B cell .a 4175 to 4498 1 to 324     Submitted on the opposite strand 324/324
(100 %)
0 diff
(100 %id)
TI_151799133   .a 4232 to 4834 99 to 701       603/701
(86 %)
7 diff
(99.1 %id)
TI_149275971   .a 4242 to 5174 1001 to 85   tiling clone, AAA   917/994
(92 %)
22 diff
(97.8 %id)
BX094398 placenta .a 4272 to 4990 1 to 717       717/717
(100 %)
3 diff
(99.6 %id)
CK430027 eye, lacrimal gland .a 4293 to 4925 1 to 633       633/633
(100 %)
0 diff
(100 %id)
FN054538 breast carcinoma .a 4319 to 4438 1 to 120       120/120
(100 %)
0 diff
(100 %id)
BU623133 cell lines, Chondrosarcoma .a 4365 to 5174 827 to 19   AAA   809/809
(100 %)
4 diff
(99.6 %id)
BF083343 colon .a 4378 to 4780 409 to 7       403/409
(98 %)
0 diff
(100 %id)
TI_154011190   .a 4429 to 5174 871 to 127   AAA   745/1108
(67 %)
4 diff
(99.7 %id)
BF035969 adenocarcinoma, ovary .a 4439 to 5168 1 to 724       724/724
(100 %)
37 diff
(94.9 %id)
BM674863 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4465 to 5174 728 to 19   AAA   710/710
(100 %)
1 diff
(99.9 %id)
AA861212   .a 4478 to 4933 1 to 456     Submitted on the opposite strand 456/456
(100 %)
1 diff
(99.8 %id)
BM968847 lung, Primary Lung Epithelial Cells .a 4492 to 5174 701 to 19   AAA   683/683
(100 %)
0 diff
(100 %id)
FN083939 breast carcinoma .a 4526 to 4596 72 to 1     Submitted on the opposite strand 72/73
(98 %)
1 diff
(98.7 %id)
FN093805 breast carcinoma .a 4526 to 4604 79 to 3     Submitted on the opposite strand 77/80
(96 %)
0 diff
(100 %id)
BM712938 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4543 to 5020 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
BM715424 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4543 to 5174 1 to 632   AAA   632/632
(100 %)
1 diff
(99.9 %id)
BM995141 Chondrosarcoma, Left Pubic Bone .a 4546 to 5174 647 to 19   AAA   629/629
(100 %)
2 diff
(99.7 %id)
FN084854 breast carcinoma .a 4558 to 4655 98 to 1     Submitted on the opposite strand 98/99
(98 %)
0 diff
(100 %id)
BU754141 placenta .a 4560 to 5174 633 to 19   AAA   615/615
(100 %)
1 diff
(99.9 %id)
BU783532 insulinoma, Pancreas .a 4566 to 5164 606 to 8     Submitted on the opposite strand 599/606
(98 %)
0 diff
(100 %id)
FN163781 breast carcinoma .a 4570 to 4668 94 to 1     Submitted on the opposite strand 94/96
(97 %)
4 diff
(95.9 %id)
FN149692 breast carcinoma .a 4619 to 4734 114 to 1     Submitted on the opposite strand 114/115
(99 %)
2 diff
(98.3 %id)
AW952455   .a 4624 to 5134 1 to 511       511/511
(100 %)
0 diff
(100 %id)
CA435811 lung, Metastatic Chondrosarcoma .a 4627 to 5174 567 to 20   AAA   548/548
(100 %)
0 diff
(100 %id)
AW444709   .a 4629 to 5176 563 to 16   AAA   548/548
(100 %)
1 diff
(99.9 %id)
AI184164   .a 4669 to 5175 509 to 4       506/509
(99 %)
0 diff
(100 %id)
DB544980 hippocampus .a 4674 to 5176 1 to 503     Submitted on the opposite strand 503/503
(100 %)
2 diff
(99.7 %id)
TI_149275168   .a 4675 to 5175 657 to 156   AAA   502/850
(59 %)
0 diff
(100 %id)
FN134874 breast carcinoma .a 4684 to 4793 1 to 107       107/115
(93 %)
4 diff
(96.6 %id)
DB547935 hippocampus .a 4706 to 5174 1 to 469     Submitted on the opposite strand 469/469
(100 %)
2 diff
(99.6 %id)
DB551843 hippocampus .a 4710 to 5173 1 to 464     Submitted on the opposite strand 464/464
(100 %)
2 diff
(99.6 %id)
DB545168 hippocampus .a 4718 to 5176 1 to 459     Submitted on the opposite strand 459/459
(100 %)
1 diff
(99.8 %id)
AA488117 whole brain .a 4729 to 5157 428 to 1     Submitted on the opposite strand 428/428
(100 %)
2 diff
(99.6 %id)
D57088   .a 4731 to 5026 1 to 296       296/298
(99 %)
1 diff
(99.7 %id)
DB547862 hippocampus .a 4734 to 5173 1 to 441     Submitted on the opposite strand 441/442
(99 %)
2 diff
(99.6 %id)
AI689301 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4734 to 5174 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
AI969467 malignant melanoma, metastatic to lymphnode, skin .a 4738 to 5175 439 to 2       438/439
(99 %)
0 diff
(100 %id)
AI624657 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 4743 to 5174 453 to 22   AAA   432/432
(100 %)
2 diff
(99.6 %id)
FN072574 breast carcinoma .a 4790 to 4895 104 to 1     Submitted on the opposite strand 104/106
(98 %)
2 diff
(98.2 %id)
AA251595 germinal center B cell .a 4791 to 5163 375 to 3     Submitted on the opposite strand 373/375
(99 %)
0 diff
(100 %id)
AA625761   .a 4815 to 5150 336 to 1       336/336
(100 %)
0 diff
(100 %id)
BE858113 brain, glioblastoma (pooled) .a 4817 to 5174 359 to 1       359/359
(100 %)
3 diff
(99.2 %id)
AA872090 pooled germ cell tumors .a 4869 to 5175 307 to 2       306/307
(99 %)
0 diff
(100 %id)
BF431948 pooled .a 4886 to 5382 497 to 1   tiling clone,   497/497
(100 %)
2 diff
(99.6 %id)
T69849 lung .a 4887 to 5175 300 to 4     Submitted on the opposite strand 297/358
(82 %)
0 diff
(100 %id)
AI887612 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 4902 to 5380 502 to 24   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 479/479
(100 %)
0 diff
(100 %id)
C21417   .a 4906 to 5094 1 to 189       189/189
(100 %)
1 diff
(99.5 %id)
AA861685   .a 4946 to 5378 436 to 4       433/436
(99 %)
0 diff
(100 %id)
BQ777574 Pancreas, Purified pancreatic islet .a 5034 to 5174 1 to 142     Submitted on the opposite strand 142/142
(100 %)
1 diff
(99.3 %id)
AA910700 carcinoid, lung .a 5084 to 5174 91 to 1       91/91
(100 %)
0 diff
(100 %id)
CR621937 Neuroblastoma Cot 10-normalized .b 1 to 1145 1 to 1145 exact tiling clone,   1145/1145
(100 %)
0 diff
(100 %id)
BF034098 adenocarcinoma, ovary .b 473 to 1194 1 to 716       716/913
(78 %)
17 diff
(98.2 %id)
AA478755 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 681 to 1112 1 to 432       432/432
(100 %)
0 diff
(100 %id)
AA418709 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 681 to 1183 1 to 503   fully sequenced, Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 503/503
(100 %)
1 diff
(99.9 %id)
BF792654 adrenal cortex carcinoma, cell line, adrenal gland .b 687 to 1193 13 to 517   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 505/517
(97 %)
4 diff
(99.3 %id)
BF792592 adrenal cortex carcinoma, cell line, adrenal gland .b 696 to 1193 17 to 516   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 506/516
(98 %)
15 diff
(97.1 %id)
TI_149304987   .b 779 to 1205 520 to 94   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 427/932
(45 %)
7 diff
(99.3 %id)
BM978478 lung, Primary Lung Epithelial Cells .b 779 to 1205 445 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 427/445
(95 %)
7 diff
(98.5 %id)
AI167998 senescent fibroblast .b 792 to 1208 421 to 5   tiling clone,   417/468
(89 %)
0 diff
(100 %id)
BE094468 breast .b 887 to 1110 24 to 250       227/250
(90 %)
9 diff
(96.4 %id)
BF996233 placenta_normal .b 926 to 1116 1 to 191       191/192
(99 %)
11 diff
(94.3 %id)
AA418701 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 950 to 1206 290 to 34   fully sequenced, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 257/257
(100 %)
0 diff
(100 %id)
NM_198793.2   .c 1 to 5288 1 to 5288 exact RefSeq,   5288/5288
(100 %)
1 diff
(100.0 %id)
BP340678 Spleen .c 31 to 606 1 to 574   tiling clone,   574/585
(98 %)
3 diff
(99.5 %id)
DA110396 cerebellum .c 32 to 575 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
CR601569 placenta .c 33 to 1292 1 to 1260 exact tiling clone,   1260/1260
(100 %)
0 diff
(100 %id)
BX439724 placenta .c 33 to 701 1 to 667   fully sequenced,   667/667
(100 %)
4 diff
(99.5 %id)
TI_57218860   .c 33 to 777 30 to 771       744/771
(96 %)
13 diff
(98.4 %id)
BM820315 stomach .c 36 to 648 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
DN993493 brain, whole brain .c 40 to 720 7 to 687       681/687
(99 %)
7 diff
(99.0 %id)
CN343704 embryonic stem cells, DMSO-treated H9 cellline .c 42 to 633 1 to 592       592/592
(100 %)
1 diff
(99.9 %id)
BP268130 thyroid .c 42 to 623 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
Z25521   .c 42 to 1303 1 to 1262 exact     1262/1270
(99 %)
2 diff
(99.9 %id)
BP218419 caudate nucleus .c 44 to 625 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BP332163 renal proximal tubule .c 44 to 623 1 to 580       580/581
(99 %)
2 diff
(99.7 %id)
BP368562 thymus .c 44 to 623 1 to 580       580/580
(100 %)
1 diff
(99.9 %id)
DA245840 brain .c 45 to 642 2 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
DA324920 hippocampus .c 45 to 594 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
BU538882 adenocarcinoma, cell line, breast .c 47 to 875 1 to 837       835/916
(91 %)
16 diff
(98.3 %id)
BU538897 adenocarcinoma, cell line, breast .c 47 to 875 1 to 829       831/903
(92 %)
16 diff
(98.3 %id)
BM831826 stomach .c 50 to 500 1 to 451       451/451
(100 %)
1 diff
(99.8 %id)
DB471289 hippocampus .c 55 to 553 1 to 500       500/500
(100 %)
3 diff
(99.4 %id)
BP247771 Kidney .c 56 to 643 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
BP323017 Pancreas .c 56 to 638 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
BP351016   .c 56 to 653 1 to 598       598/598
(100 %)
2 diff
(99.7 %id)
BP353406   .c 56 to 637 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA100288 cerebellum .c 57 to 588 2 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
AU128255   .c 57 to 785 2 to 741   capped   740/744
(99 %)
21 diff
(97.2 %id)
DA748707   .c 57 to 635 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA895301 skeletal muscle .c 57 to 541 2 to 486   capped   485/485
(100 %)
1 diff
(99.8 %id)
BP263218 small intestine .c 58 to 631 1 to 574       574/574
(100 %)
3 diff
(99.5 %id)
BP354268   .c 58 to 638 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP350016 brain .c 60 to 639 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
DA063077 cerebellum .c 61 to 641 2 to 582   capped   581/581
(100 %)
1 diff
(99.9 %id)
DA216141 brain .c 61 to 431 2 to 372   capped   371/371
(100 %)
1 diff
(99.8 %id)
DA236719 brain .c 61 to 639 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
DA992430 synovial membrane tissue from rheumatioidarthritis .c 61 to 485 2 to 426   capped   425/425
(100 %)
1 diff
(99.8 %id)
DB474863 hippocampus .c 64 to 547 1 to 484       484/484
(100 %)
1 diff
(99.8 %id)
BG699267 brain, hippocampus .c 64 to 812 1 to 749       749/751
(99 %)
13 diff
(98.3 %id)
DR001269 fetal brain .c 64 to 871 28 to 832       805/839
(95 %)
11 diff
(98.7 %id)
DB173597 kidney, tumor tissue .c 65 to 410 2 to 347   capped   346/346
(100 %)
1 diff
(99.8 %id)
BG498678 adenocarcinoma, Prostate .c 68 to 857 1 to 791       791/792
(99 %)
13 diff
(98.4 %id)
BG699681 brain, hippocampus .c 69 to 780 1 to 721       721/779
(92 %)
18 diff
(97.7 %id)
TI_44166963   .c 69 to 805 121 to 876       756/878
(86 %)
54 diff
(93.9 %id)
DA611366   .c 70 to 616 2 to 549   capped   548/550
(99 %)
5 diff
(99.1 %id)
BP350604   .c 70 to 652 1 to 583       583/583
(100 %)
5 diff
(99.2 %id)
BX438624 neuroblastoma .c 72 to 949 1 to 878       878/878
(100 %)
3 diff
(99.7 %id)
CN343705 embryonic stem cells, cell lines H1, H7, andH9 .c 75 to 518 1 to 444       444/444
(100 %)
3 diff
(99.4 %id)
BC012884 Ovary, adenocarcinoma .c 78 to 1315 1 to 1238 exact available from MGC, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 1238/1238
(100 %)
1 diff
(100.0 %id)
DB497489 hypothalamus .c 78 to 579 1 to 502       502/502
(100 %)
1 diff
(99.9 %id)
CX759342 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 80 to 778 1 to 694     Submitted on the opposite strand 694/839
(82 %)
10 diff
(98.9 %id)
CR592842 Placenta Cot 25-normalized .c 81 to 1269 1 to 1189 exact     1189/1189
(100 %)
0 diff
(100 %id)
AL553384 placenta, Placenta Cot 25-normalized .c 81 to 701 1 to 621   fully sequenced,   621/621
(100 %)
1 diff
(99.9 %id)
CD557512 testis .c 81 to 817 1 to 746       747/915
(81 %)
18 diff
(98.1 %id)
BM193858 leukopheresis .c 81 to 289 1 to 213       213/226
(94 %)
12 diff
(94.7 %id)
BM907313 large cell carcinoma, lung .c 82 to 785 1 to 704       704/1026
(68 %)
11 diff
(99.0 %id)
CA487382   .c 82 to 776 1 to 697       697/889
(78 %)
8 diff
(99.2 %id)
BM698281 eye, fetal eyes .c 82 to 320 1 to 239     Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 239/239
(100 %)
2 diff
(99.2 %id)
CX871819 embryonic stem .c 84 to 816 1 to 733       733/733
(100 %)
1 diff
(99.9 %id)
DB239734 trachea .c 84 to 677 2 to 598   capped   597/601
(99 %)
10 diff
(98.4 %id)
TI_45210133   .c 85 to 776 96 to 795   AAA   703/1278
(55 %)
22 diff
(98.3 %id)
BP222994   .c 86 to 667 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA937066 Spleen .c 86 to 662 2 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
DA350212 substantia nigra .c 91 to 657 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
BF038502 adenocarcinoma, ovary .c 91 to 739 1 to 649       649/650
(99 %)
4 diff
(99.4 %id)
BF037429 adenocarcinoma, ovary .c 92 to 833 1 to 740       740/740
(100 %)
15 diff
(98.0 %id)
BE876973 large cell carcinoma, undifferentiated, lung .c 95 to 755 1 to 655       655/658
(99 %)
9 diff
(98.7 %id)
CR591788 Placenta Cot 25-normalized .c 98 to 1292 1 to 1195 exact     1195/1195
(100 %)
0 diff
(100 %id)
AL552279 placenta, Placenta Cot 25-normalized .c 98 to 701 1 to 605   fully sequenced,   605/605
(100 %)
2 diff
(99.7 %id)
BF685188 leiomyosarcoma cell line, uterus .c 98 to 780 1 to 679       679/924
(73 %)
13 diff
(98.6 %id)
BC010016 Uterus, leiomyosarcoma .c 99 to 1315 1 to 1217 exact available from MGC, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 1217/1217
(100 %)
1 diff
(100.0 %id)
BP350546   .c 99 to 670 1 to 572       572/581
(98 %)
1 diff
(99.9 %id)
BE514853 adenocarcinoma cell line, ovary .c 100 to 775 1 to 669       669/680
(98 %)
11 diff
(98.4 %id)
BE746932 adenocarcinoma cell line, ovary .c 101 to 732 1 to 631       631/631
(100 %)
2 diff
(99.7 %id)
DB496070 hypothalamus .c 102 to 588 1 to 487       487/487
(100 %)
1 diff
(99.8 %id)
TI_45211383   .c 102 to 704 127 to 757       580/757
(76 %)
25 diff
(96.7 %id)
CR999203 T-Lymphocytes .c 103 to 909 1 to 807       807/810
(99 %)
4 diff
(99.6 %id)
DB177795 kidney, tumor tissue .c 103 to 663 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA222469 brain .c 104 to 761 2 to 659   capped   658/658
(100 %)
2 diff
(99.7 %id)
CA495264   .c 113 to 980 1 to 872       872/872
(100 %)
9 diff
(99.0 %id)
BE271355 adenocarcinoma cell line, ovary .c 118 to 785 1 to 669       669/682
(98 %)
12 diff
(98.3 %id)
BE746380 adenocarcinoma cell line, ovary .c 120 to 930 1 to 807       809/875
(92 %)
17 diff
(98.1 %id)
BU507776 leiomyosarcoma, uterus .c 121 to 965 5 to 867       863/894
(96 %)
31 diff
(96.6 %id)
BE514701 adenocarcinoma cell line, ovary .c 129 to 629 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
BE394324 endometrium, adenocarcinoma cell line, uterus .c 145 to 780 1 to 639       639/766
(83 %)
13 diff
(98.4 %id)
DR432682 mixed .c 176 to 854 1 to 670     Submitted on the opposite strand 670/676
(99 %)
22 diff
(96.8 %id)
DR433240 mixed .c 176 to 847 1 to 673     Submitted on the opposite strand 673/674
(99 %)
17 diff
(97.5 %id)
DR433201 mixed .c 176 to 781 1 to 606   fully sequenced,   606/606
(100 %)
5 diff
(99.2 %id)
DR433025 mixed .c 176 to 957 1 to 784     Submitted on the opposite strand 784/816
(96 %)
24 diff
(97.1 %id)
DR432967 mixed .c 176 to 965 1 to 789     Submitted on the opposite strand 789/811
(97 %)
12 diff
(98.6 %id)
DR432479 mixed .c 176 to 611 1 to 433   fully sequenced,   433/433
(100 %)
10 diff
(97.7 %id)
BP348930 brain .c 180 to 761 1 to 582       582/582
(100 %)
4 diff
(99.4 %id)
BT006907   .c 181 to 1096 1 to 916       916/918
(99 %)
0 diff
(100 %id)
CV023586 mixed .c 181 to 790 1 to 609       609/658
(92 %)
6 diff
(99.1 %id)
TI_1948103734   .c 181 to 575 123 to 517     Submitted on the opposite strand 395/1251
(31 %)
7 diff
(99.5 %id)
TI_1948104015   .c 181 to 701 126 to 646   fully sequenced, Submitted on the opposite strand 521/646
(80 %)
6 diff
(99.1 %id)
TI_154188992   .c 198 to 1065 49 to 908       860/998
(86 %)
13 diff
(98.7 %id)
CF128857 Chondrosarcoma Lung Metastasis cell lines, lung .c 200 to 949 1 to 750       750/750
(100 %)
0 diff
(100 %id)
CR624381 fetal liver .c 226 to 1224 1 to 999       999/999
(100 %)
0 diff
(100 %id)
AL532350 brain, fetal liver, Liver, neuroblastoma cells .c 226 to 701 1 to 475   fully sequenced,   475/475
(100 %)
9 diff
(98.2 %id)
CB177195 Pancreas, Purified pancreatic islet .c 252 to 777 11 to 536       526/536
(98 %)
7 diff
(98.7 %id)
DA210181 brain .c 266 to 834 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DR433020 mixed .c 266 to 1093 832 to 9     Submitted on the opposite strand 824/833
(98 %)
17 diff
(98.0 %id)
BM831405 stomach .c 271 to 806 1 to 536       536/536
(100 %)
0 diff
(100 %id)
DR432968 mixed .c 273 to 1093 831 to 9     Submitted on the opposite strand 823/836
(98 %)
7 diff
(99.2 %id)
BM831951 stomach .c 281 to 673 1 to 393       393/393
(100 %)
0 diff
(100 %id)
FN067048 breast carcinoma .c 313 to 377 64 to 1     Submitted on the opposite strand 64/65
(98 %)
1 diff
(98.5 %id)
CR591693 HeLa cells Cot 25-normalized .c 352 to 1273 1 to 922       922/922
(100 %)
0 diff
(100 %id)
AL555618 placenta .c 352 to 902 1 to 551   fully sequenced,   551/551
(100 %)
2 diff
(99.7 %id)
BG260711 bladder, transitional cell papilloma, cell line .c 357 to 959 1 to 603       603/604
(99 %)
1 diff
(99.9 %id)
DR433234 mixed .c 393 to 1093 711 to 9     Submitted on the opposite strand 703/711
(98 %)
4 diff
(99.5 %id)
AW178327 head_neck .c 415 to 649 235 to 1       235/235
(100 %)
0 diff
(100 %id)
DR432681 mixed .c 422 to 1093 669 to 9     Submitted on the opposite strand 661/696
(94 %)
12 diff
(98.3 %id)
DA075335 cerebellum .c 439 to 1012 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
CF128363 Chondrosarcoma Lung Metastasis cell lines, lung .c 454 to 1190 1 to 737       737/737
(100 %)
0 diff
(100 %id)
TI_154194224   .c 454 to 1292 51 to 880       830/1005
(82 %)
5 diff
(99.6 %id)
BX485255   .c 480 to 1045 4 to 570       567/570
(99 %)
6 diff
(99.0 %id)
BE929847 placenta_normal .c 513 to 1034 1 to 522       522/522
(100 %)
1 diff
(99.9 %id)
BE745477 adenocarcinoma cell line, ovary .c 542 to 1262 1 to 712       712/841
(84 %)
17 diff
(98.0 %id)
CR623329 Placenta Cot 25-normalized .c 554 to 1303 1 to 750       750/750
(100 %)
0 diff
(100 %id)
AL554590 placenta, Placenta Cot 25-normalized .c 554 to 1303 1 to 750       750/750
(100 %)
7 diff
(99.1 %id)
BG333273 large cell carcinoma, lung .c 558 to 1186 1 to 627       627/627
(100 %)
2 diff
(99.7 %id)
DR432480 mixed .c 580 to 1089 521 to 14   fully sequenced,   508/521
(97 %)
1 diff
(99.9 %id)
TI_1948103733   .c 580 to 1093 654 to 141     Submitted on the opposite strand 514/1344
(38 %)
0 diff
(100 %id)
BM713277 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 581 to 996 1 to 417       417/420
(99 %)
2 diff
(99.6 %id)
BM676392 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 593 to 1302 728 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 710/719
(98 %)
0 diff
(100 %id)
AI923277 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 619 to 1302 699 to 13   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 685/687
(99 %)
10 diff
(98.6 %id)
TI_149306203   .c 619 to 1315 788 to 92   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 697/963
(72 %)
3 diff
(99.7 %id)
BU686268 lung, Primary Lung Epithelial Cells .c 619 to 1315 717 to 21   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 697/713
(97 %)
3 diff
(99.6 %id)
BX454642 placenta .c 640 to 1292 650 to 1   fully sequenced,   650/650
(100 %)
4 diff
(99.4 %id)
AL575620 placenta, Placenta Cot 25-normalized .c 640 to 1281 653 to 12   fully sequenced,   642/653
(98 %)
1 diff
(99.9 %id)
AL576397 placenta, Placenta Cot 25-normalized .c 640 to 1226 638 to 48   fully sequenced,   591/638
(92 %)
2 diff
(99.7 %id)
AL564364 brain, fetal liver, Liver, neuroblastoma cells .c 640 to 1217 584 to 7   fully sequenced,   495/501
(98 %)
29 diff
(94.3 %id)
TI_1948104014   .c 640 to 1093 583 to 130   fully sequenced, Submitted on the opposite strand 454/583
(77 %)
0 diff
(100 %id)
AW580763 leiomios .c 645 to 1195 558 to 8       551/558
(98 %)
1 diff
(99.9 %id)
CA430110 Cell Line, Chondrosarcoma .c 666 to 1302 655 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 637/637
(100 %)
1 diff
(99.9 %id)
AW803891 uterus .c 680 to 916 1 to 237       237/237
(100 %)
1 diff
(99.6 %id)
BF036383 adenocarcinoma, ovary .c 685 to 1298 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BU738788 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 685 to 1295 636 to 26   AAA   611/618
(98 %)
1 diff
(99.9 %id)
BG163405 hypernephroma, cell line, Kidney .c 704 to 1306 1 to 603   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 603/603
(100 %)
1 diff
(99.9 %id)
AW129387 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 706 to 1303 601 to 4       598/601
(99 %)
7 diff
(98.9 %id)
AW470030 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 706 to 1303 599 to 2       598/599
(99 %)
8 diff
(98.7 %id)
BF838606 head_neck .c 732 to 1183 476 to 25     Submitted on the opposite strand 452/476
(94 %)
3 diff
(99.4 %id)
DR433197 mixed .c 748 to 1097 355 to 6   fully sequenced,   350/355
(98 %)
4 diff
(98.9 %id)
AI635480 Kidney, renal cell tumor .c 759 to 1315 574 to 20   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 555/555
(100 %)
16 diff
(97.2 %id)
W93910 heart .c 764 to 902 1 to 139   fully sequenced,   139/139
(100 %)
0 diff
(100 %id)
AL696656 human skeletal muscle .c 765 to 1258 1 to 494       494/494
(100 %)
1 diff
(99.8 %id)
BG003366 placenta_normal .c 801 to 1203 408 to 5       404/408
(99 %)
1 diff
(99.8 %id)
BE929849 placenta_normal .c 806 to 1229 434 to 10       425/434
(97 %)
5 diff
(98.9 %id)
AA918056 2 pooled tumors (clear cell type), Kidney .c 817 to 1303 487 to 3       485/487
(99 %)
9 diff
(98.2 %id)
BM667573 eye, fetal eyes .c 817 to 1320 522 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 504/504
(100 %)
0 diff
(100 %id)
BF094272 uterus_tumor .c 821 to 1232 414 to 5       410/414
(99 %)
0 diff
(100 %id)
BE880059 large cell carcinoma, undifferentiated, lung .c 825 to 1302 1 to 474   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 474/474
(100 %)
7 diff
(98.6 %id)
AI491762 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 826 to 1303 478 to 1       478/478
(100 %)
0 diff
(100 %id)
CB410561 maxilla, pooled .c 836 to 1303 1 to 468       468/468
(100 %)
0 diff
(100 %id)
AL578071 placenta .c 841 to 1273 434 to 1   fully sequenced,   434/434
(100 %)
5 diff
(98.9 %id)
W93648 heart .c 841 to 1314 478 to 1   fully sequenced,   478/478
(100 %)
5 diff
(99.0 %id)
DA107239 cerebellum .c 844 to 1386 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
AA938271 2 pooled tumors (clear cell type), Kidney .c 844 to 1303 462 to 3       460/462
(99 %)
2 diff
(99.6 %id)
AI338213 lung .c 847 to 1303 457 to 1       457/457
(100 %)
4 diff
(99.2 %id)
AI707674 aorta .c 850 to 1302 453 to 1       453/453
(100 %)
4 diff
(99.2 %id)
DB567081 hypothalamus .c 852 to 1320 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
DB543698 hippocampus .c 863 to 1302 1 to 440     Submitted on the opposite strand 440/440
(100 %)
0 diff
(100 %id)
AI708271 aorta .c 869 to 1302 433 to 1       433/434
(99 %)
4 diff
(99.1 %id)
AA455447 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 871 to 1296 7 to 432   fully sequenced,   426/432
(98 %)
6 diff
(98.7 %id)
AA588253 normal prostate, Prostate .c 871 to 1303 434 to 1       434/437
(99 %)
9 diff
(98.0 %id)
AI082024 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 877 to 1303 429 to 3       427/429
(99 %)
0 diff
(100 %id)
BF834237 head_neck .c 883 to 1232 364 to 13     Submitted on the opposite strand 352/364
(96 %)
0 diff
(100 %id)
BF315654 brain, neuroblastoma .c 884 to 1303 1 to 418       418/438
(95 %)
8 diff
(98.2 %id)
AI742309 pooled .c 895 to 1302 419 to 12   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 408/408
(100 %)
0 diff
(100 %id)
DB534762 hippocampus .c 902 to 1320 1 to 419     Submitted on the opposite strand 419/419
(100 %)
1 diff
(99.8 %id)
AA669129 lung .c 930 to 1320 391 to 1       391/391
(100 %)
0 diff
(100 %id)
DB556166 hypothalamus .c 959 to 1307 1 to 348     Submitted on the opposite strand 347/356
(97 %)
23 diff
(93.6 %id)
FN060546 breast carcinoma .c 972 to 1061 1 to 89       89/93
(95 %)
6 diff
(93.6 %id)
AA773707 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 989 to 1165 1 to 177       177/177
(100 %)
2 diff
(98.9 %id)
AA773711 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 989 to 1303 1 to 315       315/323
(97 %)
1 diff
(99.7 %id)
BF525972 brain, glioblastoma with EGFR amplification .c 1024 to 1835 1 to 805       805/955
(84 %)
44 diff
(95.4 %id)
BG164876 hypernephroma, cell line, Kidney .c 1024 to 1770 1 to 737       737/764
(96 %)
26 diff
(96.6 %id)
AA455448 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 1027 to 1315 288 to 1   fully sequenced,   288/288
(100 %)
1 diff
(99.7 %id)
CB068304 Pancreas, Purified pancreatic islet .c 1030 to 1316 287 to 1       287/287
(100 %)
0 diff
(100 %id)
W52496 senescent fibroblast .c 1036 to 1636 1 to 608       608/608
(100 %)
14 diff
(97.7 %id)
CA438524 lung, Metastatic Chondrosarcoma .c 1067 to 1302 254 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 236/241
(97 %)
1 diff
(99.6 %id)
BE072916 breast .c 1069 to 1183 117 to 3     Submitted on the opposite strand 115/117
(98 %)
0 diff
(100 %id)
BE072920 breast .c 1069 to 1183 116 to 3     Submitted on the opposite strand 114/116
(98 %)
0 diff
(100 %id)
BG189047   .c 1084 to 1303 1 to 219   AAA   219/237
(92 %)
10 diff
(95.8 %id)
BG190665   .c 1084 to 1304 1 to 219       219/219
(100 %)
7 diff
(96.9 %id)
BG191025   .c 1084 to 1304 1 to 218   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 218/218
(100 %)
7 diff
(96.8 %id)
BG193230   .c 1084 to 1304 1 to 222       222/237
(93 %)
10 diff
(95.8 %id)
BG194731   .c 1084 to 1317 1 to 230   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 230/230
(100 %)
8 diff
(96.6 %id)
BG198817   .c 1084 to 1316 1 to 234   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 234/235
(99 %)
15 diff
(93.7 %id)
BG218194   .c 1084 to 1303 1 to 219   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 219/219
(100 %)
6 diff
(97.3 %id)
BG220216   .c 1084 to 1303 1 to 222       222/223
(99 %)
18 diff
(92.0 %id)
BP417646 small intestine .c 1084 to 1303 1 to 220     Submitted on the opposite strand 220/224
(98 %)
4 diff
(98.3 %id)
BG191024   .c 1085 to 1302 1 to 218   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 218/218
(100 %)
2 diff
(99.1 %id)
BG197271   .c 1085 to 1303 1 to 219       219/257
(85 %)
7 diff
(97.3 %id)
BG199340   .c 1085 to 1310 1 to 227       227/232
(97 %)
19 diff
(91.9 %id)
BG207637   .c 1085 to 1302 1 to 219   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 219/219
(100 %)
3 diff
(98.7 %id)
BG208179   .c 1085 to 1302 1 to 218   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 218/218
(100 %)
4 diff
(98.2 %id)
BG228005   .c 1085 to 1302 1 to 219   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 219/219
(100 %)
4 diff
(98.2 %id)
BG191661   .c 1086 to 1315 1 to 230   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 230/230
(100 %)
4 diff
(98.3 %id)
BG208811   .c 1086 to 1302 1 to 217   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 217/217
(100 %)
1 diff
(99.6 %id)
BG182241   .c 1087 to 1302 1 to 216   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 216/216
(100 %)
2 diff
(99.1 %id)
BG213408   .c 1087 to 1305 46 to 266   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 221/266
(83 %)
6 diff
(97.8 %id)
BG181725   .c 1088 to 1302 1 to 215   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 215/215
(100 %)
1 diff
(99.6 %id)
BG184852   .c 1088 to 1302 1 to 215   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 215/215
(100 %)
1 diff
(99.6 %id)
BG187473   .c 1088 to 1320 1 to 232   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 232/232
(100 %)
1 diff
(99.6 %id)
BG187982   .c 1088 to 1315 1 to 228   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 228/228
(100 %)
2 diff
(99.2 %id)
BG206624   .c 1088 to 1302 1 to 213   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 213/213
(100 %)
4 diff
(98.2 %id)
BG213409   .c 1088 to 1321 3 to 235   AAA   233/242
(96 %)
2 diff
(99.2 %id)
BG213964   .c 1088 to 1290 10 to 212   AAA   203/224
(90 %)
10 diff
(95.6 %id)
BG215033   .c 1088 to 1302 1 to 214   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 214/214
(100 %)
2 diff
(99.1 %id)
BG215581   .c 1088 to 1302 1 to 215   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 215/215
(100 %)
3 diff
(98.7 %id)
BG203453   .c 1089 to 1303 6 to 223       218/224
(97 %)
6 diff
(97.4 %id)
BG209768   .c 1089 to 1304 3 to 217   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 215/217
(99 %)
6 diff
(97.3 %id)
BG211298   .c 1089 to 1302 1 to 214   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 214/214
(100 %)
5 diff
(97.7 %id)
BG202410   .c 1091 to 1320 52 to 280   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 229/280
(81 %)
6 diff
(97.9 %id)
BG207136   .c 1091 to 1311 50 to 270   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 221/270
(81 %)
7 diff
(97.5 %id)
BG217712   .c 1091 to 1315 4 to 228   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 225/228
(98 %)
6 diff
(97.4 %id)
BG181724   .c 1094 to 1302 8 to 216   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 209/216
(96 %)
11 diff
(95.0 %id)
BG198284   .c 1094 to 1302 7 to 215   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 209/215
(97 %)
3 diff
(98.7 %id)
BG213963   .c 1097 to 1315 15 to 233   AAA   219/238
(92 %)
10 diff
(95.8 %id)
BG215580   .c 1097 to 1315 16 to 234   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 219/234
(93 %)
6 diff
(97.5 %id)
AW769296 colon, moderately-differentiated adenocarcinoma .c 1105 to 1317 213 to 1       213/213
(100 %)
0 diff
(100 %id)
AA279095 germinal center B cell .c 1109 to 1317 214 to 6       209/214
(97 %)
0 diff
(100 %id)
BM453691 melanotic melanoma, skin .c 1113 to 2011 1 to 901   tiling clone,   901/902
(99 %)
12 diff
(98.7 %id)
DA238891 brain .c 1122 to 1709 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
FN105533 breast carcinoma .c 1130 to 1240 111 to 2     Submitted on the opposite strand 110/111
(99 %)
0 diff
(100 %id)
GD142317   .c 1164 to 1302 1 to 139   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 139/139
(100 %)
6 diff
(95.7 %id)
GD160458   .c 1166 to 1303 1 to 139       139/155
(89 %)
4 diff
(97.5 %id)
GD160476   .c 1166 to 1303 1 to 139       139/155
(89 %)
8 diff
(94.9 %id)
GD145988   .c 1170 to 1302 1 to 133   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 133/133
(100 %)
5 diff
(96.3 %id)
BU566476 mixed (pool of 40 RNAs) .c 1186 to 1318 1 to 133   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 133/133
(100 %)
2 diff
(98.5 %id)
AI932456 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1190 to 1315 138 to 13   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 126/126
(100 %)
0 diff
(100 %id)
CU450151 epidermis .c 1233 to 1979 7 to 753       747/753
(99 %)
6 diff
(99.3 %id)
DA236349 brain .c 1311 to 1825 2 to 519   capped   518/518
(100 %)
3 diff
(99.5 %id)
DA942913 Spleen .c 1314 to 1808 2 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
BU430643 lymph .c 1322 to 1714 1 to 393       393/393
(100 %)
6 diff
(98.5 %id)
TI_154152070   .c 1328 to 1870 81 to 624       544/544
(100 %)
15 diff
(97.3 %id)
BI598271 brain, hypothalamus .c 1367 to 2168 1 to 805       805/867
(92 %)
6 diff
(99.4 %id)
TI_45210815   .c 1367 to 1997 86 to 717       632/717
(88 %)
6 diff
(99.2 %id)
TI_154167218   .c 1372 to 1975 78 to 683       606/794
(76 %)
20 diff
(97.5 %id)
DB219164 trachea .c 1458 to 1992 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
DB476185 hippocampus .c 1466 to 1954 1 to 490       490/490
(100 %)
4 diff
(99.2 %id)
DB476414 hippocampus .c 1466 to 1951 1 to 486       486/486
(100 %)
1 diff
(99.8 %id)
DN919487   .c 1517 to 2127 1 to 611       611/611
(100 %)
5 diff
(99.2 %id)
AA431947   .c 1551 to 1766 1 to 216       216/216
(100 %)
2 diff
(99.1 %id)
DB163615 thymus .c 1623 to 2203 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
BE161728 head_neck .c 1640 to 2023 383 to 1     Submitted on the opposite strand 383/383
(100 %)
2 diff
(99.5 %id)
AW474332 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1660 to 2198 540 to 1       540/540
(100 %)
3 diff
(99.5 %id)
DA402281 thalamus .c 1756 to 2307 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
AW474342 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1756 to 2198 444 to 1       444/444
(100 %)
3 diff
(99.4 %id)
DA125065 cerebellum .c 1791 to 2330 2 to 542   capped   541/541
(100 %)
3 diff
(99.5 %id)
DA809592 brain .c 1823 to 2358 2 to 536   tiling clone, capped   535/537
(99 %)
3 diff
(99.5 %id)
DA990931 synovial membrane tissue from rheumatioidarthritis .c 2072 to 2611 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA188308 amygdala .c 2143 to 2682 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DB540028 hippocampus .c 2147 to 2665 1 to 519     Submitted on the opposite strand 519/519
(100 %)
2 diff
(99.7 %id)
AA443174 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2147 to 2664 11 to 528   fully sequenced,   518/528
(98 %)
8 diff
(98.5 %id)
N42850 melanocyte .c 2160 to 2641 1 to 483       483/484
(99 %)
4 diff
(99.2 %id)
AA235129 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2160 to 2581 1 to 422     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
DB365422   .c 2170 to 2665 502 to 1       502/511
(98 %)
15 diff
(97.1 %id)
DB568597 hypothalamus .c 2175 to 2665 1 to 491     Submitted on the opposite strand 491/491
(100 %)
0 diff
(100 %id)
DN915363   .c 2184 to 2607 1 to 424       424/424
(100 %)
3 diff
(99.3 %id)
TI_45210997   .c 2205 to 2229 923 to 946       831/946
(87 %)
10 diff
(99.0 %id)
AA463483 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2246 to 2666 421 to 1   fully sequenced,   421/421
(100 %)
0 diff
(100 %id)
BF439618 pooled .c 2253 to 2811 559 to 1       559/559
(100 %)
0 diff
(100 %id)
BM992707 lung, Metastatic Chondrosarcoma .c 2275 to 2812 556 to 19   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 538/538
(100 %)
1 diff
(99.9 %id)
AI018009 pooled .c 2312 to 2812 501 to 1       501/501
(100 %)
1 diff
(99.9 %id)
AW573242 pooled .c 2330 to 2812 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
AI417258 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2332 to 2812 481 to 1   tiling clone,   481/481
(100 %)
0 diff
(100 %id)
AW439062 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 2363 to 2671 310 to 2       309/310
(99 %)
0 diff
(100 %id)
AI167170 pooled .c 2367 to 2811 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
AA836627 germinal center B cell .c 2384 to 2822 439 to 1       439/439
(100 %)
3 diff
(99.4 %id)
AA443828   .c 2388 to 2816 429 to 1       429/429
(100 %)
0 diff
(100 %id)
AW592922 pooled .c 2403 to 2812 429 to 20   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 410/410
(100 %)
1 diff
(99.8 %id)
BM846171 myeloma .c 2419 to 2966 1 to 548       548/548
(100 %)
0 diff
(100 %id)
AI766583 B-cell, chronic lymphotic leukemia .c 2433 to 2812 381 to 1       381/381
(100 %)
1 diff
(99.8 %id)
CN343702 embryonic stem cells, DMSO-treated H9 cellline .c 2484 to 2812 1 to 329   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 329/329
(100 %)
0 diff
(100 %id)
AK096670   .c 2532 to 5074 1 to 2538   tiling clone, available from FLJ,   2538/2538
(100 %)
10 diff
(99.7 %id)
DA813974   .c 2533 to 3105 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
FN097099 breast carcinoma .c 2574 to 2665 1 to 90       90/91
(98 %)
3 diff
(96.8 %id)
DA266640 caudate nucleus .c 2719 to 3267 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
GD149878   .c 2741 to 2822 1 to 82       82/85
(96 %)
4 diff
(95.3 %id)
R56420 whole brain .c 2827 to 3329 1 to 504     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 504/505
(99 %)
7 diff
(98.7 %id)
N39976 melanocyte .c 2917 to 3342 1 to 427       427/427
(100 %)
1 diff
(99.8 %id)
AA234955 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2928 to 3142 242 to 28   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 215/215
(100 %)
0 diff
(100 %id)
BX953191   .c 2955 to 3586 1 to 632   tiling clone,   632/632
(100 %)
0 diff
(100 %id)
DB170046 kidney, tumor tissue .c 2997 to 3571 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
AW994425 breast_normal .c 3060 to 3517 1 to 457       457/457
(100 %)
9 diff
(98.1 %id)
D81879 brain .c 3099 to 3529 1 to 431       431/431
(100 %)
0 diff
(100 %id)
AA383529 testis .c 3262 to 3431 1 to 170       170/170
(100 %)
0 diff
(100 %id)
DB349309 trachea .c 4533 to 5082 550 to 1   tiling clone,   550/550
(100 %)
0 diff
(100 %id)
DB327626   .c 4544 to 5082 539 to 1       539/539
(100 %)
0 diff
(100 %id)
R56421 whole brain .c 4939 to 5082 164 to 21   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 144/144
(100 %)
0 diff
(100 %id)
BU160164 testis .d 1 to 769 1 to 771   tiling clone,   771/772
(99 %)
12 diff
(98.5 %id)
DA879620 Prostate .d 565 to 1153 2 to 591   capped   590/590
(100 %)
2 diff
(99.7 %id)
TI_149289281   .d 619 to 1243 749 to 126   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 624/624
(100 %)
9 diff
(98.6 %id)
BF085961 placenta_normal .d 626 to 1123 511 to 10       502/511
(98 %)
5 diff
(99.1 %id)
AI432621 Prostate .d 679 to 1249 574 to 4       571/575
(99 %)
1 diff
(99.9 %id)
AI701980 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 694 to 1231 540 to 3   tiling clone,   538/541
(99 %)
2 diff
(99.7 %id)
AI270167 colon, moderately-differentiated adenocarcinoma .d 717 to 1231 516 to 1       516/516
(100 %)
14 diff
(97.3 %id)
AI476785 pooled .d 799 to 1230 443 to 12   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 432/432
(100 %)
0 diff
(100 %id)
AI857345 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 810 to 1245 437 to 2   tiling clone,   436/437
(99 %)
4 diff
(99.1 %id)
AA937302 pooled .d 955 to 1209 17 to 278     Submitted on the opposite strand 269/263
(102 %)
9 diff
(96.6 %id)
AA960793 pooled .d 955 to 1209 2 to 263     Submitted on the opposite strand 269/263
(102 %)
9 diff
(96.6 %id)
AA972834 pooled .d 955 to 1209 2 to 263     Submitted on the opposite strand 269/263
(102 %)
9 diff
(96.6 %id)
AW818444 stomach .d 963 to 1119 163 to 9       155/171
(90 %)
1 diff
(99.5 %id)
T39172 lung .d 983 to 1219 1 to 237   fully sequenced,   237/237
(100 %)
0 diff
(100 %id)
BE041733 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 991 to 1230 242 to 1       242/296
(81 %)
2 diff
(99.4 %id)
T40454 lung .d 1004 to 1231 228 to 1   fully sequenced,   228/228
(100 %)
3 diff
(98.7 %id)
CD706459 normal nasopharynx .e 1 to 653 19 to 671 exact tiling clone,   653/671
(97 %)
6 diff
(99.2 %id)
DN912748   .e 459 to 989 531 to 1   tiling clone,   531/531
(100 %)
4 diff
(99.3 %id)
BP233033 muscle .f 1 to 582 1 to 581 F175L I176F C177V P178L G179V ... tiling clone,   581/581
(100 %)
2 diff
(99.7 %id)
AW749412 breast .f 318 to 840 1 to 530   tiling clone,   530/530
(100 %)
37 diff
(93.1 %id)
BY994703   .g 1 to 488 15 to 502 exact tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 494/502
(98 %)
6 diff
(98.9 %id)
CN272830 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1 to 738 1 to 738 exact tiling clone,   738/738
(100 %)
1 diff
(99.9 %id)
BF351077 head_neck .h 420 to 970 548 to 1       548/548
(100 %)
12 diff
(97.9 %id)
BE162871 head_neck .h 562 to 1035 482 to 9     Submitted on the opposite strand 474/482
(98 %)
0 diff
(100 %id)
BX506325   .h 601 to 1251 10 to 661   tiling clone,   652/661
(98 %)
6 diff
(99.1 %id)
BY996376   .h 820 to 1470 26 to 676   tiling clone,   651/676
(96 %)
6 diff
(99.2 %id)
AA381345   .h 978 to 1257 1 to 280       280/283
(98 %)
2 diff
(99.3 %id)
DB499568 hypothalamus .h 1260 to 1739 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
DB504107 hypothalamus .h 1260 to 1733 1 to 474       474/475
(99 %)
1 diff
(99.8 %id)
DA422976   .h 1278 to 1815 2 to 539   tiling clone, capped   538/538
(100 %)
1 diff
(99.9 %id)
R31499 placenta .h 1353 to 1644 1 to 301   fully sequenced,   301/301
(100 %)
8 diff
(97.4 %id)
R31500 placenta .h 1614 to 1938 337 to 1   tiling clone, fully sequenced,   337/337
(100 %)
10 diff
(97.1 %id)
AA447463   .h 1918 to 2356 1 to 438   tiling clone,   438/438
(100 %)
2 diff
(99.6 %id)
BY799776 eye .h 1969 to 2584 1 to 616       616/616
(100 %)
0 diff
(100 %id)
CN313320 embryonic stem cells, DMSO-treated H9 cellline .h 2017 to 2785 1 to 769   tiling clone,   769/769
(100 %)
0 diff
(100 %id)
AI700535 carcinoid, lung .h 2040 to 2508 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AL710413 human skeletal muscle .h 2054 to 2591 1 to 538       538/538
(100 %)
1 diff
(99.9 %id)
DN916821   .h 2160 to 2765 1 to 606       606/606
(100 %)
1 diff
(99.9 %id)
CN278194 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 2900 to 3575 7 to 675   tiling clone,   669/675
(99 %)
6 diff
(99.2 %id)
BX642794   .h 3019 to 3672 1 to 653       653/653
(100 %)
2 diff
(99.7 %id)
BX471206   .h 3054 to 3516 1 to 463       463/463
(100 %)
0 diff
(100 %id)
BX477208   .h 3086 to 3674 1 to 589   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 589/589
(100 %)
2 diff
(99.7 %id)
DB312934   .h 3110 to 3674 565 to 1       565/565
(100 %)
1 diff
(99.9 %id)
DB570697 hypothalamus .h 3201 to 3674 1 to 474     Submitted on the opposite strand 474/474
(100 %)
3 diff
(99.4 %id)
DB575354 hypothalamus .h 3210 to 3674 1 to 465     Submitted on the opposite strand 465/465
(100 %)
3 diff
(99.4 %id)
AA446657   .h 3220 to 3683 463 to 1       463/463
(100 %)
3 diff
(99.4 %id)
BX108604 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 3234 to 3688 455 to 1   tiling clone, Submitted on the opposite strand 455/455
(100 %)
0 diff
(100 %id)
AI653886 serous papillary carcinoma, high grade, 2pooled tumors, uterus .h 3243 to 3675 433 to 1       433/433
(100 %)
2 diff
(99.6 %id)
AA973803 carcinoid, lung .h 3258 to 3674 416 to 1       416/416
(100 %)
4 diff
(99.1 %id)
AW419262 endometrioid ovarian metastasis, ovary .h 3318 to 3674 384 to 28   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 357/357
(100 %)
0 diff
(100 %id)
DA322073 hippocampus .i 1 to 640 2 to 641 exact tiling clone, to resequence, capped   640/640
(100 %)
1 diff
(99.9 %id)
BM152519 leukopheresis .i 531 to 955 1 to 425   tiling clone,   425/425
(100 %)
2 diff
(99.6 %id)
BX645723   .i 682 to 1108 1 to 427       427/427
(100 %)
1 diff
(99.8 %id)
BX478875   .i 727 to 1195 1 to 470       470/470
(100 %)
8 diff
(98.3 %id)
DB164775 thymus .i 823 to 1415 2 to 593   tiling clone, capped   592/592
(100 %)
1 diff
(99.9 %id)
DA223340 brain .i 879 to 1439 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DB140519 thymus .i 1388 to 1937 2 to 552   tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
DA148697 amygdala .i 1519 to 2017 2 to 501   tiling clone, capped   500/500
(100 %)
1 diff
(99.8 %id)
DB309158 hippocampus .i 2692 to 3277 586 to 1   tiling clone, to resequence,   586/586
(100 %)
1 diff
(99.9 %id)
DB347074 thymus .i 2726 to 3264 541 to 1   tiling clone,   541/541
(100 %)
3 diff
(99.5 %id)
DB301605 amygdala .i 2762 to 3277 516 to 1   tiling clone,   516/516
(100 %)
0 diff
(100 %id)
DB156004 thymus .j 1 to 603 2 to 604   tiling clone, to resequence, capped   603/603
(100 %)
1 diff
(99.9 %id)
DB142578 thymus .j 364 to 893 2 to 531   tiling clone, capped   530/530
(100 %)
0 diff
(100 %id)
DA674422   .j 469 to 1012 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
CN282673 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .j 529 to 1300 13 to 786 exact tiling clone,   774/786
(98 %)
6 diff
(99.3 %id)
DB346492 thymus .j 1963 to 2494 534 to 1   tiling clone, to resequence,   534/534
(100 %)
2 diff
(99.7 %id)
AK124152 thymus .k 1 to 2211 2 to 2211 K72R tiling clone, available from FLJ,   2211/2211
(100 %)
5 diff
(99.8 %id)
CN364844 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 239 to 846 1 to 607       607/607
(100 %)
1 diff
(99.9 %id)
CN364840 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 262 to 945 1 to 684   tiling clone,   684/687
(99 %)
5 diff
(99.3 %id)
CN364843 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 370 to 836 1 to 467       467/467
(100 %)
0 diff
(100 %id)
BE568658 bladder, carcinoma, cell line .k 377 to 956 1 to 580       580/896
(64 %)
22 diff
(97.6 %id)
AA009406 heart .k 1397 to 1881 1 to 485   fully sequenced,   485/485
(100 %)
0 diff
(100 %id)
BX105659 heart .k 1399 to 2128 1 to 731   tiling clone,   731/733
(99 %)
3 diff
(99.6 %id)
N77111 multiple sclerosis lesions .k 1465 to 1765 1 to 306       306/306
(100 %)
24 diff
(92.2 %id)
AL599772   .k 1650 to 1953 13 to 317       305/317
(96 %)
8 diff
(97.5 %id)
BM144921 leukopheresis .k 1661 to 2210 568 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 550/551
(99 %)
0 diff
(100 %id)
N62182 multiple sclerosis lesions .k 1786 to 2236 453 to 1   tiling clone,   453/455
(99 %)
3 diff
(99.4 %id)
AW105521 ovary, tumor, 5 pooled (see description) .k 1792 to 2224 463 to 31   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
CV320060 uterus_tumor .k 1850 to 2158 1 to 311       311/313
(99 %)
26 diff
(91.7 %id)
AA009747 heart .k 1851 to 2226 381 to 5   tiling clone, fully sequenced,   377/381
(98 %)
0 diff
(100 %id)
AL708216 human skeletal muscle .l-u 1 to 729 1 to 730   tiling clone,   730/730
(100 %)
1 diff
(99.9 %id)
CN364842 embryonic stem cells, cell lines H1, H7, andH9 .l-u 24 to 602 1 to 579       579/580
(99 %)
1 diff
(99.9 %id)
DB104079 thymus .l-u 49 to 602 2 to 554   capped   553/553
(100 %)
3 diff
(99.5 %id)
DA820586 pericardium .l-u 58 to 625 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
AI765286 2 pooled tumors (clear cell type), Kidney .l-u 160 to 638 480 to 1       480/480
(100 %)
27 diff
(94.4 %id)
AW297086   .l-u 270 to 640 383 to 13   tiling clone, AAA   371/371
(100 %)
0 diff
(100 %id)
BQ049048 lymph, lymphoma, cell line .l-u 693 to 1552 1 to 876 F50L V51F T52V L53T M55L ... tiling clone,   876/1020
(85 %)
25 diff
(97.6 %id)
BE542249 cervix .l-u 717 to 1301 1 to 579       579/974
(59 %)
30 diff
(97.0 %id)
CN364841 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l-u 822 to 997 1 to 176       176/176
(100 %)
3 diff
(98.3 %id)
BI032401 nervous_normal .l-u 1190 to 1395 265 to 59       207/265
(78 %)
0 diff
(100 %id)
BF897644 marrow .l-u 1192 to 1411 24 to 243       220/243
(90 %)
6 diff
(97.6 %id)
AA683294 schizophrenic brain S-11 frontal lobe .l-u 1199 to 1646 1 to 448 exact   Submitted on the opposite strand 448/448
(100 %)
1 diff
(99.8 %id)
BI020741 marrow .l-u 1362 to 1719 365 to 8   tiling clone,   358/365
(98 %)
0 diff
(100 %id)
BG569783 lung .l-u 1533 to 1925 1 to 394   tiling clone,   394/731
(53 %)
7 diff
(99.1 %id)
AJ713898 bone marrow .l-u 1597 to 1691 1 to 94       94/94
(100 %)
3 diff
(96.9 %id)
TI_149281039   .m-u 1 to 738 54 to 791 L2G   Submitted on the opposite strand 738/792
(93 %)
9 diff
(98.9 %id)
BM983263 lung, Primary Lung Epithelial Cells .m-u 8 to 705 1 to 698   tiling clone, Submitted on the opposite strand 698/698
(100 %)
1 diff
(99.9 %id)
AA732231 germinal center B cell .m-u 163 to 638 485 to 10       476/485
(98 %)
0 diff
(100 %id)
AL700103 human skeletal muscle .m-u 196 to 1024 1 to 831       831/831
(100 %)
6 diff
(99.3 %id)
BM697721 eye, fetal eyes .m-u 242 to 851 1 to 611       611/611
(100 %)
1 diff
(99.9 %id)
AA687261 germinal center B cell .m-u 243 to 638 398 to 2       397/398
(99 %)
0 diff
(100 %id)
BQ002786 Chondrosarcoma, Left Pelvis .m-u 259 to 1003 758 to 17   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 742/742
(100 %)
4 diff
(99.5 %id)
BE840868 stomach_normal .m-u 309 to 897 6 to 601       596/604
(98 %)
38 diff
(93.8 %id)
BE090006 breast .m-u 310 to 702 8 to 401       394/401
(98 %)
6 diff
(98.6 %id)
BF373785 stomach_normal .m-u 311 to 799 6 to 493       488/493
(98 %)
6 diff
(98.8 %id)
R78992 placenta .m-u 332 to 689 1 to 367       367/459
(79 %)
13 diff
(97.2 %id)
C05259 heart .m-u 446 to 753 1 to 308       308/308
(100 %)
0 diff
(100 %id)
BG230614 blood, lymphocyte .m-u 460 to 1002 544 to 2   tiling clone,   543/544
(99 %)
0 diff
(100 %id)
BY994485   .m-u 467 to 1001 598 to 64   AAA Submitted on the opposite strand 535/560
(95 %)
0 diff
(100 %id)
AA381338   .m-u 498 to 772 1 to 275       275/275
(100 %)
3 diff
(99.0 %id)
BM151464 leukopheresis .m-u 504 to 1001 512 to 18   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 495/495
(100 %)
7 diff
(98.6 %id)
AA535376 colon .m-u 508 to 1015 507 to 1       507/519
(97 %)
5 diff
(99.1 %id)
AW166867 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 510 to 1002 499 to 7       493/499
(98 %)
0 diff
(100 %id)
AW276245 lung, two pooled squamous cell carcinomas .m-u 520 to 1001 482 to 1       482/482
(100 %)
0 diff
(100 %id)
AI889115 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .m-u 556 to 1001 476 to 32   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 445/445
(100 %)
10 diff
(97.8 %id)
AI884496 serous papillary carcinoma, high grade, 2pooled tumors, uterus .m-u 583 to 1002 420 to 1       420/420
(100 %)
0 diff
(100 %id)
BE047226 ovary, serous papillary tumor .m-u 607 to 1001 410 to 16   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 395/395
(100 %)
0 diff
(100 %id)
AA953028 Kidney, kidney tumor .m-u 636 to 1002 367 to 1       367/367
(100 %)
0 diff
(100 %id)
AA969906 pooled .m-u 663 to 1020 365 to 8       358/365
(98 %)
0 diff
(100 %id)
TI_149284261   .m-u 673 to 1001 407 to 80   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 328/790
(41 %)
4 diff
(99.5 %id)
BU680434 lung, Primary Lung Epithelial Cells .m-u 673 to 1001 346 to 19   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 328/348
(94 %)
4 diff
(98.9 %id)
AW137558   .m-u 677 to 1000 1 to 324     Submitted on the opposite strand 324/325
(99 %)
9 diff
(97.3 %id)
AA777967   .m-u 717 to 1002 289 to 4       286/289
(98 %)
0 diff
(100 %id)
BQ716614 sympathetic trunk .m-u 751 to 1704 1 to 952   tiling clone,   952/952
(100 %)
6 diff
(99.4 %id)
AW015585   .n 1 to 612 630 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 613/613
(100 %)
1 diff
(99.9 %id)
AW015582   .n 86 to 612 544 to 18   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 527/527
(100 %)
2 diff
(99.7 %id)
AW974380   .n 129 to 486 108 to 465       358/465
(76 %)
10 diff
(97.9 %id)
AI283110 placenta .n 149 to 612 481 to 18   AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 464/464
(100 %)
0 diff
(100 %id)
AJ712491 bone marrow .n 222 to 494 1 to 272       272/272
(100 %)
3 diff
(98.9 %id)
DA058849 cerebellum .n 240 to 770 2 to 532 exact tiling clone, capped   531/531
(100 %)
0 diff
(100 %id)
AW779173 pooled .n 264 to 613 352 to 3       350/352
(99 %)
1 diff
(99.8 %id)
BM171911 lung .o 1 to 628 1 to 627 exact tiling clone,   627/627
(100 %)
13 diff
(98.0 %id)
BF438962 pooled .o 391 to 750 360 to 1   tiling clone,   360/360
(100 %)
0 diff
(100 %id)
AW195549 pooled .o 397 to 763 368 to 1   tiling clone,   368/368
(100 %)
1 diff
(99.8 %id)
DB139009 thymus .p 1 to 453 2 to 455   tiling clone, capped   454/454
(100 %)
1 diff
(99.8 %id)
BX953501   .p 272 to 724 1 to 452 I73M tiling clone,   452/452
(100 %)
5 diff
(98.9 %id)
BM702820 eye, Retina Foveal and Macular .q 1 to 549 1 to 547 G42D L43* tiling clone,   547/547
(100 %)
2 diff
(99.7 %id)
AI016116   .q 121 to 589 472 to 5   tiling clone,   468/472
(99 %)
4 diff
(99.2 %id)
AI208596   .q 211 to 589 384 to 6       379/384
(98 %)
0 diff
(100 %id)
BX490813   .r 1 to 547 1 to 547 exact tiling clone,   547/547
(100 %)
3 diff
(99.5 %id)
DB214450 trachea .s-u 1 to 494 2 to 495 exact tiling clone, capped   494/494
(100 %)
0 diff
(100 %id)
AW662894 pooled .t 1 to 467 477 to 11 exact AAA Possibly primed on the genome, locally A rich (28/28 A in genome downstream of last aligned base) 467/467
(100 %)
1 diff
(99.8 %id)
BX470944   .u-u 1 to 433 1 to 435 S20P R21I tiling clone,   435/435
(100 %)
9 diff
(98.0 %id)
GD151325   .u-u 5 to 247 7 to 249   tiling clone, AAA   243/249
(97 %)
6 diff
(97.6 %id)
AV755985 bone marrow .va-u 1 to 373 73 to 445 exact tiling clone, AAA   373/383
(97 %)
6 diff
(98.5 %id)
AL712159 human skeletal muscle .va-u 1 to 372 1 to 372 exact tiling clone, AAA   372/372
(100 %)
0 diff
(100 %id)
AA976090 leiomyosarcoma, soft tissue .vb 1 to 319 319 to 1 G17V tiling clone,   319/319
(100 %)
16 diff
(95.0 %id)
AL832675 adipose Gene CD47, variant not shown       available from DKFZ, Suspected internal deletion, this clone was ignored    
BX640889 fetal kidney Gene CD47, variant not shown       available from DKFZ, AAA Suspected internal deletion, this clone was ignored    
CN343703 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene CD47, variant not shown         This clone was ignored    
BC042889 testis Gene CD47, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BC045593 Brain, hypothalamus Gene CD47, variant not shown       available from MGC, AAA Suspected internal deletion, this clone was ignored    
BM750659 Ascites, stomach Gene CD47, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m-u, .n, .o, .p, .q, .r, .s-u, .t, .u-u, .va-u, .vb Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI